Versant Diagnostics (Iron Path Capital) Acquires Addison Central Pathology

Versant Diagnostics Acquires Two Chicago-Area Pathology Practices

July 11, 2022

Healthcare Services

Versant Diagnostics, a PE-backed independent physician services company, acquired Pathology Consultants of Chicago and the operating assets of Elgin Laboratory Physicians to expand its footprint in the greater-Chicago market. The deals (Versant's third and fourth acquisitions in nine months) support the company's strategy to consolidate pathology practices and accelerate digital pathology conversion with growth capital backing from Iron Path Capital and financing support from Principal.

Versant Diagnostics Acquires Associate Pathologists of Joliet, Ltd.

May 14, 2024

Healthcare Services

Versant Diagnostics, a physician services platform backed by Iron Path Capital, has acquired Associate Pathologists of Joliet, Ltd., a multi-specialty pathology practice based in Joliet, Illinois. The deal expands Versant’s nationwide pathology network and increases its presence in the Midwest while enabling additional services and collaboration through Versant’s digital pathology resources.

Versant Diagnostics Acquires Cutaneous Pathology, P.A.

August 20, 2024

Healthcare Services

Versant Diagnostics, an independent physician services company based in Grapevine, Texas, has acquired Cutaneous Pathology, P.A., a dermatopathology practice in Winston-Salem, North Carolina. As part of the transaction, internationally recognized dermatopathologist Dr. Omar P. Sangueza has joined Versant to expand its national network of dermatopathology specialists.

VION Biosciences Acquires Ansh Labs

August 29, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Ansh Labs, an immunoassay development and reagent manufacturer based in Houston, Texas. The add-on expands VION's diagnostics capabilities — adding GMP IVD manufacturing and ISO 13485 certification — and broadens the platform's product and service offerings for clinical diagnostics, research, and pharmaceutical development.

Versiti Acquires Pearl Pathways

November 7, 2023

Healthcare Services

Versiti, a Milwaukee-based blood health organization, has acquired Pearl Pathways, an Indianapolis-area life science consulting firm that provides regulatory affairs, quality compliance, CRO services and an independent IRB. The acquisition expands Versiti's clinical trial and life-sciences service capabilities, enabling earlier and deeper support for product development across biopharmaceutical, medical device, and diagnostics clients.

Fulgent Genetics Acquires Inform Diagnostics from Avista Capital Partners

April 18, 2022

Healthcare Services

Fulgent Genetics agreed to acquire Inform Diagnostics, a leading national independent pathology laboratory headquartered in Irving, Texas, for approximately $170 million. The acquisition from Avista Capital Partners expands Fulgent’s pathology and anatomic testing menu, adds nationwide commercial and managed-care relationships, and broadens its geographic lab footprint to support cross-selling of genomic and pathology services.